MoTrPAC: UC Preclinical Animal Study Site
MoTrPAC: UC Preclinical Animal Study Site
批准号:
10830200
负责人:
Sue C Bodine
金额:
$8.7万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-15 至 2024-11-30
中文摘要
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT
The University of California Preclinical Animal Study Site (UC PASS) is a collaborative effort between UC
Davis and UC San Diego that brings together the scientific expertise, state of the art technologies and facilities,
and institutional support to achieve the primary objectives goals of the PASS, which are to: 1) develop animal
models that best complement the endurance and resistance training protocols used in the human trials, and 2)
provide organ and tissue samples collected at multiple time points after both acute and chronic exercise for
analysis by the Chemical Analysis Sites. The animal studies to be undertaken by the PASS will begin to
elucidate the molecular pathways responsible for the acute and chronic effects of both endurance and
resistance exercise on individual organs, as well as identify the interactions between organs; the goal being to
understand the mechanisms by which different modes of physical activity impart their health benefits. In order
to reach this goal, experts in model development and phenotyping of the resulting muscle and global health
adaptations will be essential. The UC PASS team has exactly these traits. The team acknowledges that the
ultimate animal model and exercise tests to be utilized in the PASS will be determined by the Molecular
Transducers of Physical Activity Common (MoTrPAC) Steering Committee. In this application we provide a
strong rationale and justification for the use of the rat as the animal model and propose specific endurance and
resistance exercise programs to be used in Phase I of the PASS, highlighting the major advantages and
limitations of each paradigm. In Phase II of the PASS we build on the models established in Phase I and
propose three specific aims to begin to produce a standard curve of molecular transducers versus adaptive
response to exercise. In Phase II we propose to exercise animals of increasing age or increasing adiposity,
determine the adaptive response to 12 weeks of training, and relate this with the acute molecular transducer
response to exercise. With this secondary screen, we will be able to identify molecular transducers that directly
correlate with the local or global health benefits of exercise. We will then use this information to test the genetic
requirement for these molecular transducers for the health benefits of exercise. The UC PASS is composed of
an exceptional team of primary investigators and key collaborators/advisors with expertise in the development
of animal models of exercise, the molecular response to exercise, and applied human exercise interventions.
This team will provide leadership and the necessary skill sets to successfully model human exercise in
animals, which is essential to the success of the MoTrPAC Common Fund and achievement of its goal: to
define and understand the cellular and molecular mechanisms of the human health benefits of physical activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MoTrPAC: UC Preclinical Animal Study Site - Supplement
-
批准号:10746582
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2023
-
负责人:Sue C Bodine
-
依托单位:
Sarcopenia and recovery from Disuse-Induced Atrophy
-
批准号:10361323
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Sue C Bodine
-
依托单位:
Sarcopenia and recovery from Disuse-Induced Atrophy
-
批准号:10549727
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Sue C Bodine
-
依托单位:
The Role of Intramuscular Lipids in Muscle Anabolic Resistance
-
批准号:9461483
-
项目类别:
-
资助金额:$47.17万
-
财政年份:2017
-
负责人:Sue C Bodine
-
依托单位:
The Role of Intramuscular Lipids in Muscle Anabolic Resistance
-
批准号:9128358
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2016
-
负责人:Sue C Bodine
-
依托单位:
MoTrPAC: UC Preclinical Animal Study Site
-
批准号:10341097
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2016
-
负责人:Sue C Bodine
-
依托单位:
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response
-
批准号:8548959
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Sue C Bodine
-
依托单位:
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response
-
批准号:8838187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Sue C Bodine
-
依托单位:
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response
-
批准号:8277635
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Sue C Bodine
-
依托单位:
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response
-
批准号:8839282
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Sue C Bodine
-
依托单位:
Glucocorticoid control of gene expression during skeletal muscle atrophy
-
批准号:8012965
-
项目类别:
-
资助金额:$1.04万
-
财政年份:2010
-
负责人:Sue C Bodine
-
依托单位:
Glucocorticoid control of gene expression during skeletal muscle atrophy
-
批准号:7847816
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2009
-
负责人:Sue C Bodine
-
依托单位:
Glucocorticoid control of gene expression during skeletal muscle atrophy
-
批准号:7548120
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2008
-
负责人:Sue C Bodine
-
依托单位:
Glucocorticoid control of gene expression during skeletal muscle atrophy
-
批准号:8012819
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2008
-
负责人:Sue C Bodine
-
依托单位:
国内基金
海外基金
登录
查看更多内容
六君焦仙汤通过调节肠道菌群影响Trp/AhR通路治疗UC的作用机制研究
-
批准号:2026JJ80334
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李振龙
-
依托单位:
从肠道菌群-胆汁酸-内质网应激轴研究胃苓汤调控PERK-eIF2α-ATF4-CHOP通路干预脾虚湿盛证UC的机制
-
批准号:2026JJ81066
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡莹
-
依托单位:
基于“去宛陈莝,精生形盛”探讨白芍七物颗粒通过CDK4/6-CCND1/2/3-ATM通路时序调控UC肠黏膜细胞周期与DNA损伤修复的机制研究
-
批准号:2026JJ81083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨宗亮
-
依托单位:
基于16S rDNA测序联合代谢组学探讨中药金汁对UC大鼠肠道菌群的影响
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:洪中华
-
依托单位:
基于TGR5/HIF-1α通路调控巨噬细胞代谢重编程研究清肠消澼饮治疗UC大肠湿热证的效应机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:秦书敏
-
依托单位:
UC-MSC通过趋化轴抑制巨噬细胞浸润改善系统性硬化症早期纤维化的机制研究
-
批准号:82560328
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:米日班姑·阿力甫
-
依托单位:
芍药汤调控C5a/C5aR1/Mpo正反馈环抑制NETs激活改善UC肠黏膜炎症损伤的机制研究
-
批准号:82505496
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:王玥梅
-
依托单位:
“浊毒”视角下槐花散抑制铁死亡促进UC上皮屏障修复的分子机制:聚焦“STAT1-SLC7A11分子开关”介导的GSH代谢
-
批准号:82505591
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:李磊
-
依托单位:
从巨噬细胞极化调控炎症及肿瘤微环境探究UC-CRC的发病机制及中医药干预研究
-
批准号:2025JJ90101
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:余炼
-
依托单位:
“厚肠愈疡”理论下温清止利法调控CTLA-4+ILC3s细胞重塑UC肠黏膜免疫稳态的作用机制研究
-
批准号:82505460
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:张阳
-
依托单位: